Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. - Wikidata - awgldk - TriplyDB

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.

http://www.wikidata.org/entity/Q44790441

about

Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration Uveitis and gender: the course of uveitis in pregnancy Emerging therapies for neovascular age-related macular degeneration: state of the art Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.Endoplasmic reticulum stress and diabetic retinopathy.Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis Diabetic macular edema: new trends in management.A prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema.Neodymium: yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema The management of diabetic macular oedema Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study.Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.Intraocular pressure alterations following intravitreal triamcinolone acetonide.The effects of injection site on the reflux following intravitreal injections.Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide.Effects of intravitreal triamcinolone acetonide injection with and without preservative.Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema.Corticosteroid-induced glaucoma: a review of the literature.National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation Intravitreal triamcinolone acetonide: a change in a paradigm.Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.Use of intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion The effects of intravitreal ophthalmic medications on intraocular pressure.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Steroid-induced iatrogenic glaucoma.Drug safety evaluation of intravitreal triamcinolone acetonide.Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.Complications of intravitreal injections in patients with diabetes.Side-effects of anti-inflammatory therapy in uveitis.Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone

P2860

Q24201624-68B95647-13B9-45BB-995C-562BC7C2F935 Q24243503-9F3A4787-1DF6-4995-A762-03734E13F8EB Q26864267-90C81915-80E8-4E73-AC57-9AFC025392E6 Q28253918-5AC89619-0910-4F22-8146-DAB7CE7B971C Q30850809-EB230C19-DA6D-456F-A2A5-546B003997C9 Q30863562-52D92B11-DAFC-4B26-BBFF-2AF88F296732 Q33352111-1D51D4BA-DA84-4C0B-8C7F-71D8CAE96F27 Q34014954-70E24C20-7F50-42EE-B448-E0606F714643 Q34091784-FF819D3F-05BD-4BDD-BEB0-71BF9785E86A Q34107543-8D45306F-22B6-4277-9F10-272A4FE1C2A8 Q34161986-0CDB013B-C979-44FE-AEA3-5778FE53C20B Q34605896-E3227630-A519-442F-B50A-91A1CBBC011B Q34942261-E7088465-DB47-450F-9BF1-169A447FC4A4 Q34957921-A40DDAF3-24AC-43B4-A99A-51FA703A39A1 Q35030923-12BEB217-9767-4515-A4F6-659D03C476EA Q35359052-182A4690-3277-4869-B72B-957F0A274C3E Q35761642-81EA124A-7890-47AB-83CE-E1E23EAC782E Q35762005-2F9771B5-7ECF-473D-B911-51974FFE3BEE Q35850012-0A8438C5-7CEA-47FC-B19A-C4E0F40589AB Q35924285-F35D962C-9700-4143-8E41-2B09E08E6A08 Q35953960-2AB41794-FFAD-4A87-A2F2-60B5D890644E Q35956280-69640552-4780-4DB3-AC1A-3FCC630FA5EA Q36025868-CD99BB20-D383-4A65-9F51-17547271F4B2 Q36118249-85C201DA-3D08-4A93-A60D-7FDD30C82FDC Q36378901-693CD672-3948-4C51-AD84-B7DCBDFE2834 Q36441711-9FE25DB5-0493-40FC-9125-D0A7127F6A44 Q36490459-ABC83E83-C806-41F9-9A6F-EDAD7F7BE6F4 Q36500994-A30259F0-05F7-4FE7-938D-F8E122A6A52F Q36549150-A7A61AF5-3F60-412E-A9D7-F8E6E34ECD5A Q36622491-70D86235-F66F-4EFF-AF7F-A08FFF052582 Q37223019-BDDFF20B-9453-49FE-8218-3E90234AA7F4 Q37448469-CEF3C5AB-EF00-43FA-B85C-1CF1B4926B41 Q37477129-715D30C1-A42D-4B76-A735-FCF0E8BDE3AE Q37901293-626E1461-DE09-40AD-85A7-E89A11E6F2F0 Q37953969-1CF6FF2E-E55B-4428-A909-A6B7FB1A261F Q38219895-7AF77E90-A9CA-4076-A3C3-F43CA984C56B Q38261106-FB7E8DE8-0F2B-4F8E-B3E9-3DBCE781FF35 Q38261127-99026861-096E-4ADA-9812-E41E8AC2800E Q39898518-F9C6D27D-DF38-447F-A26E-9805861395BA Q41350550-954B1412-EC68-4C17-894B-C9E77964E674

P2860

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.

http://www.wikidata.org/entity/Q44790441

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Safety of an intravitreal inje ...... m a randomized clinical trial.

@en

Safety of an intravitreal inje ...... m a randomized clinical trial.

@nl

type

label

Safety of an intravitreal inje ...... m a randomized clinical trial.

@en

Safety of an intravitreal inje ...... m a randomized clinical trial.

@nl

prefLabel

Safety of an intravitreal inje ...... m a randomized clinical trial.

@en

Safety of an intravitreal inje ...... m a randomized clinical trial.

@nl

P1433

Q44790441-06030CB2-68E9-4515-A0BA-11BCA3CCC9E3

P1476

Q44790441-7B34E387-E0C0-49A1-86E1-0404EA4AF33C

P2093

Q44790441-0FC67A72-ACAB-4260-B0F0-7B4642FC735D

Q44790441-53164B74-5D72-4216-B212-02B15093EA4D

Q44790441-64F91421-E730-462F-B01E-BAC8155F9B84

Q44790441-68315B6B-4069-46B1-9D96-86964DE83F98

Q44790441-C965DF98-C633-4143-9D7C-AA30C9AF9B33

Q44790441-F5917428-F1CD-4B59-AF40-93C508CAE532

Q44790441-FAFC9B92-40D2-4F40-BF30-3F79FFFB96E0

P304

Q44790441-E24EC163-72DB-4F28-BAB1-BF629E843157

P31

Q44790441-2B63FA0F-087F-4D8E-87CB-03FECCF6A158

P356

Q44790441-8EAC8001-4540-4D7D-833A-2C7E083B8667

P407

Q44790441-76A113BF-B300-468A-B72F-1975641417E6

P433

Q44790441-704DA3F3-CA0E-41DD-8DAE-01AE32DBC425

P478

Q44790441-67DDCEB9-EC82-4E7E-9583-BACB25D09D6B

P50

Q44790441-0A108C41-9A78-461C-87B7-2DCCAD4FED19

Q44790441-BD332C78-C437-4BF5-A348-5F5050D191AC

P577

Q44790441-B1395A79-94B6-46B9-B26E-E5175D4AE1AE

P5875

Q44790441-F7026169-053D-4508-B8A3-5118A7AE6810

P698

Q44790441-46EB7462-D3D7-476E-B6F5-996ACD17E6A2

P356

ARCHOPHT.122.3.336

P1433

JAMA Ophthalmology

P1476

Safety of an intravitreal inje ...... m a randomized clinical trial.

@en

P2093

Alex B L Hunyor

http://www.w3.org/2001/XMLSchema#string

Frank A Billson

http://www.w3.org/2001/XMLSchema#string

Mark C Gillies

http://www.w3.org/2001/XMLSchema#string

Meidong Zhu

http://www.w3.org/2001/XMLSchema#string

Philip Penfold

http://www.w3.org/2001/XMLSchema#string

Wei Luo

http://www.w3.org/2001/XMLSchema#string

William Chua

http://www.w3.org/2001/XMLSchema#string

P304

336-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.122.3.336

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7750818

http://www.w3.org/2001/XMLSchema#string

P698

15006845

http://www.w3.org/2001/XMLSchema#string